Pathological assessments at 23 weeks showed invasive carcinoma in 9 out of 10 wild-type mice, contrasting with its presence in just 1 out of 10 Cav2-/- counterparts (Fig. 7A–C). The gene discussed is CAV2; the disease is invasive carcinoma.